U.S. District Judge Joseph Goodwin, who is handling the consolidated Digitek lawsuits in West Virginia, has issued a pretrial order appointing Co-Lead Attorneys and members of the Plaintiffs’ Steering Committee in the MDL, or Multidistrict Litigation. These lawyers will perform services that benefit all of the plaintiffs during pretrial phase of the litigation. Continued
All Posts Tagged With: "digitalis toxicity"
Congress Requests Information from FDA about Digitek Recall
The U.S. House Committee on Energy and Commerce has requested information from the FDA about a May 2008 Digitek recall issued by Actavis Totowa, as well as other regulatory issues involving the same generic drug maker in recent years. Continued
Federal Digitek Lawsuits Consolidated in Southern District of West Virginia
The United States Judicial Panel on Multidistrict Litigation has ordered that all Digitek lawsuits filed as a result of allegedly defective and double strength digoxin tablets, be transferred to the Southern District of West Virginia for consolidation through pretrial litigation. Continued
Digitek Recall Lawsuits
On April 25, 2008, a nationwide Digitek Tablet Recall was issued for all lots of the heart medication. Manufacturing problems caused some tablets to contain twice as much of the active ingredient as is appropriate. This could result in digitalis toxicity in patients with impaired kidney function, which is a serious and potentially fatal illness. Continued
Following Digitek Recall, Class Action Suits have been filed
At least two class action suits have been filed on behalf of individuals who used the heart drug Digitek (digoxin). The suits come less than three weeks after all lots of Digitek were recalled on April 25th when it was discovered that some tablets sold over the past year could be twice as thick as is appropriate and contain double the approved amount of active ingredient. Continued
